ProPhase Labs Stock Options

PRPH Stock  USD 0.69  0.28  28.87%   
ProPhase Labs' latest option contracts expiring on February 20th 2026 are carrying combined implied volatility of 1.83. The ProPhase Labs option chain provides detailed quote and price information for the current ProPhase Labs option contracts. It shows all of ProPhase Labs' listed puts, calls, expiration dates, strike prices, and other pricing information.

In The Money vs. Out of Money Option Contracts on ProPhase Labs

Analyzing ProPhase Labs' in-the-money options over time can help investors to take a profitable long position in ProPhase Labs regardless of its overall volatility. This is especially true when ProPhase Labs' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money ProPhase Labs' options could be used as guardians of the underlying stock as they move almost dollar for dollar with ProPhase Labs' stock while costing only a fraction of its price.

ProPhase Labs In The Money Call Balance

When ProPhase Labs' strike price is surpassing the current stock price, the option contract against ProPhase Labs stock is said to be in the money. When it comes to buying ProPhase Labs' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on ProPhase Labs are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

ProPhase Current Options Market Mood

ProPhase Labs' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps ProPhase Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Unfortunately, most ProPhase Labs' options investors are not very successful. ProPhase Labs' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current ProPhase contract

Base on the Rule 16, the options market is currently suggesting that ProPhase Labs will have an average daily up or down price movement of about 0.11% per day over the life of the 2026-02-20 option contract. With ProPhase Labs trading at USD 0.69, that is roughly USD 7.89E-4. If you think that the market is fully incorporating ProPhase Labs' daily price movement you should consider buying ProPhase Labs options at the current volatility level of 1.83%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing ProPhase Labs options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" ProPhase calls. Remember, the seller must deliver ProPhase Labs stock to the call owner when a call is exercised.

ProPhase Labs Option Chain

When ProPhase Labs' strike price is surpassing the current stock price, the option contract against ProPhase Labs stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
ProPhase Labs' option chain is a display of a range of information that helps investors for ways to trade options on ProPhase. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for ProPhase. It also shows strike prices and maturity days for a ProPhase Labs against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
PRPH260220C0000750007.50.0 - 0.00.0Out
Call
PRPH260220C0000500005.00.0 - 0.00.0Out
Call
PRPH260220C0000250002.50.0 - 0.00.0Out
Call
PRPH260220C0000200002.00.0 - 0.050.05Out
Call
PRPH260220C0000150001.50.0 - 0.050.05Out
Call
PRPH260220C0000100001.00.0 - 0.050.05Out
Call
PRPH260220C0000050000.50.0 - 0.050.03In
 Put
PRPH260220P0000050000.50.0 - 1.21.2Out
 Put
PRPH260220P0000100001.00.45 - 0.950.9In
 Put
PRPH260220P0000150001.50.65 - 2.10.65In
 Put
PRPH260220P0000200002.01.15 - 1.951.85In
 Put
PRPH260220P0000250002.50.0 - 0.00.0In
 Put
PRPH260220P0000500005.00.0 - 0.00.0In
 Put
PRPH260220P0000750007.50.0 - 0.00.0In

ProPhase Labs Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

ProPhase Total Stockholder Equity

Total Stockholder Equity

6.99 Million

As of now, ProPhase Labs' Total Stockholder Equity is increasing as compared to previous years.

ProPhase Labs Corporate Management

Billy WhiteConsultantProfile
Stu HollensheadChief OfficerProfile
Sergio MirallesExecutive DiagnosticsProfile
Steven CPAChief OfficerProfile
Kevin QuinnChief GenomicsProfile
When determining whether ProPhase Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ProPhase Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prophase Labs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prophase Labs Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProPhase Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProPhase Labs. If investors know ProPhase will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProPhase Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.95)
Earnings Share
(19.80)
Revenue Per Share
1.402
Quarterly Revenue Growth
(0.38)
Return On Assets
(0.23)
The market value of ProPhase Labs is measured differently than its book value, which is the value of ProPhase that is recorded on the company's balance sheet. Investors also form their own opinion of ProPhase Labs' value that differs from its market value or its book value, called intrinsic value, which is ProPhase Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProPhase Labs' market value can be influenced by many factors that don't directly affect ProPhase Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProPhase Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProPhase Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProPhase Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.